Contact this trialFirst, we need to learn more about you.
ARD-101 for Prader-Willi Syndrome
Recruiting1 awardPhase 2
Palo Alto, California
This trial is testing a new drug to treat Prader-Willi Syndrome, a rare genetic disorder that causes intellectual disability, behavior problems, and obesity. The trial will assess the safety and efficacy of the drug in patients with the syndrome.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.